Anne Marie
Investor Relations
Replay available
Cellectar Biosciences, Inc. (CLRB) Q3 2025 Earnings Call
Cellectar Biosciences, Inc. (NASDAQ: CLRB) Q3 2025 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chad Coley
Chief Financial Officer
Jim Caruso
President and CEO
Jeff Jones
Analyst, Oppenheimer
Jonathan Ashkoff
Analyst, Roth
Jared Lancour
Chief Operating Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cellectar Biosciences, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.099 Good morning, ladies and gentlemen, and welcome to the SelectR Biosciences third quarter 00:00:05.099 -- 00:00:10.447 2025 earnings call. At this time, all lines are in listen-only 00:00:10.447 -- 00:00:15.155 mode. Following the presentation, we will conduct a question and answer session. 00:00:15.155 -- 00:00:20.403 If at any time during this call you require immediate assistance, please press 00:00:20.403 -- 00:00:25.651 star zero for the operator. This call is being recorded on Thursday, November 00:00:25.651 -- 00:00:27.751 13, 2025. 00:00:28.904 -- 00:00:35.151 I would now like to turn the conference over to Jim Caruso, President 00:00:35.151 -- 00:00:37.232 and CEO. 00:00:38.155 -- 00:00:42.841 Thank you, Operator. Good morning, and welcome to Selectar Bioscience's third quarter 00:00:42.841 -- 00:00:47.546 2025 financial results and business update conference call. 00:00:47.546 -- 00:00:52.692 Joining us today from Selectar are Jim Caruso, President and CEO, who will provide 00:00:52.692 -- 00:00:56.937 an overview of the company's progress before turning the call over to Chad Coley, in 00:00:56.937 -- 00:01:00.268 CFO, for a financial review of the quarter. 00:01:00.268 -- 00:01:05.314 Following this, Jared Lancour, Chief Operating Officer, will give an update on the company's 00:01:05.314 -- 00:01:10.578 progress and plans for its promising clinical development pipeline of radiopharmaceuticals. 00:01:10.921 -- 00:01:14.766 Selectar issued a press release earlier this morning detailing the content of today's 00:01:14.766 -- 00:01:19.893 call. A copy can be found on the investor page of Selectar's corporate website. 00:01:19.893 -- 00:01:24.133 I want to remind callers that the information discussed on the call today is cov...